Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Efficacy of yttrium-90 synovectomy across a spectrum of arthropathies in an era of improved disease modifying drugs and treatment protocols

Wong Y, Cherk MH, Powell A, Cicuttini F, Bailey M, Kalff V

(2014), Int J Rheum Dis, 17(1), 78-83

Mandatory influenza vaccination of healthcare workers: is it necessary or sufficient to protect patients?

Cheng AC, Worth LJ

(2014), Healthcare Infect, 19(3), 114-5

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014

Fleming S, Yannakou CK, Haeusler GM, Clark J, Grigg A, Heath CH, Bajel A, van Hal SJ, Chen SC, Milliken ST, Morrissey CO, Tam CS, Szer J, Weinkove R, Slavin MA

(2014), Intern Med J, 44(12b), 1283-97

Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction

Wong G, Trevillyan JM, Fatou B, Cinel M, Weir JM, Hoy JF, Meikle PJ

(2014), PLoS One, 9(4), e94810

Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand

van Hal SJ, Gilroy NM, Morrissey CO, Worth LJ, Szer J, Tam CS, Chen SC, Thursky KA, Slavin MA

(2014), Intern Med J, 44(12b), 1277-82

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Rasmussen TA, Tolstrup M, Brinkmann C, Olesen R, Erikstrup C, Solomon A, Winkelmann A, Palmer SE, Dinarello CA, Buzon MJ, Lichterfield M, Lewin SR, Østergaard LJ, SØgaard OS

(2014), Lancet HIV, 1(1), e13-21

Determinants of suicide and accidental or violent death in the Australian HIV Observational Database

McManus H, Petoumenos K, Franic T, Kelly MD, Watson J, O'Connor CC, Jeanes M, Hoy J, Cooper DA, Law MG; Australian HIV Observational Database

(2014), PLoS One, 9(2), e89089

Medical graduates' knowledge of bloodborne viruses and occupational exposures

Koehler N, Vujovic O, Dendle C, McMenamin C

(2014), Am J Infect Control, 42(2), 203-5

The significance of HIV 'blips' in resource-limited settings: is it the same? analysis of the treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD)

Kanapathipillai R, McManus H, Kamarulzaman A, Lim PL, Templeton DJ, Law M, Woolley I.

(2014), PLoS One, 9(2), e86122

Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy

Haskelberg H, Mallon PW, Hoy J, Amin J, Moore C, Phanuphak P, Ferret S, Belloso WH, Boyd MA, Cooper DA, Emery S

(2014), J Acquir Immune Defic Syndr, 67(2), 161-8

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel

Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA; International Antiviral Society-USA Panel

(2014), JAMA, 312(4), 410-25

Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy [SMART] Study

Dawood FZ, Roediger MP, Grandits G, Miller D, Fisher M, Zhang ZM, Hodder S, Hoy JF, Lundgren JD, Neaton JD, Soliman EZ; INSIGHT SMART Study Group

(2014), J Electrocardiol, 47(2), 264-71

Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks

Bloch M, Tong WW, Hoy J, Baker D, Lee FJ, Richardson R, Carr A; TROP (Switch from Tenofovir to Raltegravir for Low Bone Density) study team

(2014), HIV Med, 15(6), 373-80

CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals

Bastidas S, Graw F, Smith MZ, Kuster H, Günthard HF, Oxenius A

(2014), J Immunol, 192(4), 1732-44

What has the Young Physician Leaders Programme achieved?

Giles ML, Vincent FB, Volkenstein S, Shefin SM, Silva A, Fredrick F; Young Physician Leadership Group 2013

(2014), Lancet, 384(9937), 26-7

Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period

Macesic N, Morrissey CO, Cheng AC, Spencer A, Peleg AY

(2014), Transpl Infect Dis, 16(6), 887-96

Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014

Morrissey CO, Gilroy NM, Macesic N, Walker P, Ananda-Rajah M, May M, Heath CH, Grigg A, Bardy PG, Kwan J, Kirsa SW, Slavin M, Gottlieb T, Chen S

(2014), Intern Med J, 44(12b), 1298-314

Bringing new HIV infections to zero - opportunities and challenges offered by antiretroviral-based prevention in Asia, the Pacific and beyond: An overview of this special issue

Zablotska IB, Whittaker B, de Wit J, Kamarulzaman A, Ananworanich J, Wright E, Poynten IM, Mayer K

(2014), Sex Health, 11(2), 97-100

Neuro OIs: developed and developing countries

Wright EJ

(2014), Curr Opin HIV AIDS, 9(6), 539-44

Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?

Woolley IJ, Ayoub S, Crowe SM, Westhorpe C, Cherry CL, Visvanathan K, Morand E

(2014), AIDS, 28(11), 1693-4

27 28 29 30 31